Shawn Olsson
Known title: Chief Commercial OfficerCIK: 0002015796
Associated companies
Transaction History
| LENZ | ▲ Buy | Option Exercise | 10,000 | $21K | 11/17/2025 | View on chart |
| LENZ | ▼ Sell | Open Market | 4,212 | $108K | 11/17/2025 | View on chart |
| LENZ | ▼ Sell | Open Market | 5,788 | $153K | 11/17/2025 | View on chart |
| LENZ | ▲ Buy | Option Exercise | 1,400 | $3K | 4/9/2025 | View on chart |
| LENZ | ▲ Buy | Option Exercise | 3,333 | $7K | 12/16/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
LENZ Therapeutics faces cash concerns amid low trading levels
A recent analysis highlights LENZ Therapeutics' cash position as a key point of interest for observers. The stock is currently trading near its 52-week low, with an RSI indicating oversold conditions. While analyst targets vary widely, the focus remains on the company's financial liquidity and operational sustainability.
LENZ Therapeutics faces cash concerns amid low trading levels. A recent analysis highlights LENZ Therapeutics' cash position as a key point of interest for observers. The stock is currently trading near its 52-week low, with an RSI indicating oversold conditions. While analyst targets vary widely, the focus remains on the company's financial liquidity and operational sustainability.